INMB
Price:
$1.24
Market Cap:
$32.97M
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancie...[Read more]
Industry
Biotechnology
IPO Date
2019-02-04
Stock Exchange
NASDAQ
Ticker
INMB
According to INmune Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.12M. This represents a change of -32.05% compared to the average of 19.31M of the last 4 quarters.
The mean historical Enterprise Value of INmune Bio, Inc. over the last ten years is 90.53M. The current 13.12M Enterprise Value has changed 1.35% with respect to the historical average. Over the past ten years (40 quarters), INMB's Enterprise Value was at its highest in in the September 2021 quarter at 266.59M. The Enterprise Value was at its lowest in in the September 2016 quarter at 0.
Average
90.53M
Median
82.54M
Minimum
17.76M
Maximum
184.63M
Discovering the peaks and valleys of INmune Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 249.96%
Maximum Annual Enterprise Value = 184.63M
Minimum Annual Increase = -75.54%
Minimum Annual Enterprise Value = 17.76M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 17.76M | -75.54% |
| 2024 | 72.60M | -59.00% |
| 2023 | 177.06M | 130.50% |
| 2022 | 76.81M | -26.82% |
| 2021 | 104.96M | -43.15% |
| 2020 | 184.63M | 249.96% |
| 2019 | 52.76M | -41.02% |
| 2018 | 89.45M | 1.34% |
| 2017 | 88.27M | 115.16% |
| 2016 | 41.02M | 2.72% |
The current Enterprise Value of INmune Bio, Inc. (INMB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
89.14M
5-year avg
89.84M
10-year avg
90.53M
INmune Bio, Inc.’s Enterprise Value is less than CEL-SCI Corporation (14.04M), greater than Barinthus Biotherapeutics plc (-28771394.00), greater than Aligos Therapeutics, Inc. (6.87M), greater than Tempest Therapeutics, Inc. (11.64M), greater than OnKure Therapeutics, Inc. (-134267880.00), less than Mersana Therapeutics, Inc. (91.27M), less than Skye Bioscience, Inc. (19.58M), less than X4 Pharmaceuticals, Inc. (161.10M), less than PDS Biotechnology Corporation (52.81M), greater than FibroGen, Inc. (11.12M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 14.04M | $7.42M | |
| -28771394.00 | $27.41M | |
| 6.87M | $32.67M | |
| 11.64M | $5.60M | |
| -134267880.00 | $57.43M | |
| 91.27M | $145.36M | |
| 19.58M | $27.67M | |
| 161.10M | $377.28M | |
| 52.81M | $58.61M | |
| 11.12M | $36.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INmune Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like INmune Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is INmune Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for INmune Bio, Inc. (INMB)?
What is the 3-year average Enterprise Value for INmune Bio, Inc. (INMB)?
What is the 5-year average Enterprise Value for INmune Bio, Inc. (INMB)?
How does the current Enterprise Value for INmune Bio, Inc. (INMB) compare to its historical average?